Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
209.50
+3.50 (1.70%)
May 29, 2025, 1:30 PM CST
TPEX:3218 Revenue
Universal Vision Biotechnology had revenue of 1.12B TWD in the quarter ending March 31, 2025, with 4.86% growth. This brings the company's revenue in the last twelve months to 4.28B, up 3.77% year-over-year. In the year 2024, Universal Vision Biotechnology had annual revenue of 4.23B with 3.58% growth.
Revenue (ttm)
4.28B
Revenue Growth
+3.77%
P/S Ratio
4.15
Revenue / Employee
10.67M
Employees
401
Market Cap
17.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.23B | 146.05M | 3.58% |
Dec 31, 2023 | 4.08B | 588.20M | 16.83% |
Dec 31, 2022 | 3.49B | 862.26M | 32.76% |
Dec 31, 2021 | 2.63B | 578.66M | 28.18% |
Dec 31, 2020 | 2.05B | 634.16M | 44.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Oneness Biotech | 117.33M |
Lumosa Therapeutics | 43.59M |